[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-352189-en":3,"doc-seo-352189-105":51,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30,"preview_page_count":31,"preview_urls":32},352189,962090883892,"pixelkiddo","https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658",8,"Research & Report","A pan-cancer analysis of MEX3D in human tumors","Background: MEX3D, an RNA-binding protein in the MEX3 family, is proposed as a cancer regulatory molecule, yet its roles across tumor types remain insufficiently characterized. Methods: A pan-cancer evaluation of MEX3D was performed using TCGA, GTEx, and CPTAC transcriptomic and proteomic datasets, integrating expression profiles, clinical associations, survival, genetic alterations, RNA modification links, immune infiltration, and functional enrichment. Results: MEX3D shows marked mRNA/protein dysregulation across cancers, correlates with stage, predicts poor OS/DSS in multiple malignancies, and relates to TMB/MSI, immune regulators, and pathway enrichment. Conclusion: Findings support MEX3D as a cancer-specific prognostic biomarker tied to immune microenvironment and post-transcriptional regulatory networks.","Zhang et al. Discover Oncology (2026) 17:1328 Discover Oncology  \n[https://doi.org/10.1007/s12672-026-05511-1](https://doi.org/10.1007/s12672-026-05511-1)  \nANALYSIS Open Access  \nA pan-cancer analysis of MEX3D in human tumors  \nXuezhong Zhang1†, Wen Xu2†, Xiaolei Wang3, Chengbin Lei1, Meilin Gao1, Tingting Chu1, Xuebin Zhang2* and Tonggang Liu4*  \n†Xuezhong Zhang and Wen Xu share first authorship.  \n*Correspondence: Xuebin Zhang [Tank10@126.com](Tank10@126.com)  \nTonggang Liu [liutonggang123@126.com](liutonggang123@126.com)[ ](liutonggang123@126.com)1Department of Laboratory Medicine, Zibo Central Hospital, Zibo, Shandong, China 2Department of Anorectal Surgery, Dongying People’s Hospital (Dongying Hospital of Shandong Provincial Hospital Group), Dongying, China  \n3Department of Public Health, Zibo Central Hospital, Zibo, Shandong, China  \n4Department of Infectious Diseases, Shandong Medical and Pharmaceutical University Hospital, Binzhou, Shandong, China  \nAbstract  \nBackground MEX3D, a member of the MEX3 RNA-binding protein family, has emerged as a potential regulatory molecule in cancer. However, its role across different tumor types remains largely unexplored.  \nMethods We conducted a pan-cancer analysis of MEX3D using transcriptomic and proteomic data from the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and Clinical Proteomic Tumor Analysis Consortium (CPTAC) . Expression patterns, clinical correlations, survival outcomes, genetic alterations, RNA modification associations, immune infiltration, and functional enrichment were systematically evaluated.  \nResults MEX3D was significantly dysregulated in numerous cancers at both mRNA and protein levels. Its expression correlated with tumor stage in ACC, LIHC, OV, SKCM, and THCA. Elevated MEX3D expression was associated with poor overall survival (OS) and disease-specific survival (DSS) in multiple malignancies, including ACC, LGG, LUAD, and MESO. Genetic alteration analysis revealed frequent amplifications and mutations, particularly in SARC and OV. MEX3D was positively correlated with RNA modificationrelated genes (m1A, m5C, m6A) and immune regulatory genes such as CD276, TGFB1, VEGFA, and ICOSLG. Additionally, MEX3D expression showed significant associations with tumor mutational burden (TMB), microsatellite instability (MSI), and cancerassociated fibroblast infiltration. Functional enrichment analyses indicated that MEX3Drelated genes are involved in reproductive cellular processes, RNA binding, the Hippo signaling pathway, and microRNA-related oncogenic pathways.  \nConclusion This pan-cancer analysis highlights the heterogeneous expression and cancer-specific prognostic significance of MEX3D. MEX3D is associated with immune infiltration, immune regulatory genes, RNA modification-related genes, TMB/MSI, and pathways involved in gene regulation and tumor progression. These findings suggest that MEX3D may participate in cancer-specific post-transcriptional and microenvironmental regulatory networks.  \nKeywords MEX3D, Pan-cancer analysis, Gene expression, Tumor microenvironment, Immune infiltration, Biomarker  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exce","cbCaicvDb1GuTXh6","https://ap.wps.com/l/cbCaicvDb1GuTXh6","pdf",10172047,7,1,19,"English","en",105,"# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the purpose of this pan-cancer analysis of MEX3D?\",\"answer\":\"To clarify the relationship between MEX3D expression and tumor biology across diverse human cancer types, addressing the gap left by limited cross-cancer understanding.\"},{\"question\":\"Which datasets and molecular levels were used to evaluate MEX3D?\",\"answer\":\"Transcriptomic and proteomic data from TCGA, GTEx, and CPTAC were analyzed, assessing both mRNA and protein expression patterns.\"},{\"question\":\"What clinical relevance is reported for MEX3D expression?\",\"answer\":\"MEX3D dysregulation correlates with tumor stage in several cancers and is associated with poor overall survival and disease-specific survival across multiple malignancies.\"}]","A pan-cancer analysis of MEX3D in human tumors | PDF",1790098212,48,4,[33,37,42,47],{"page_no":21,"url":34,"width":35,"height":36},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4dd11feb2b0606052c32cf4cbeec9c4f.webp",983,1310,{"page_no":38,"url":39,"width":40,"height":41},2,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c1fc12e5389c15f41dc30142ee3688d.webp",982,1309,{"page_no":43,"url":44,"width":45,"height":46},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5509fa507af04f5395316fae1fe0848d.webp",981,1308,{"page_no":31,"url":48,"width":49,"height":50},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a5b9ebd4708d631a02c6b8cd7ca8bba.webp",980,1306,{"code":4,"msg":52,"data":53},"ok",{"site_id":25,"language":24,"slug":54,"title":13,"keywords":55,"description":14,"schema_data":56,"social_meta":110,"head_meta":112,"extra_data":114,"updated_unix":115},"a-pan-cancer-analysis-of-mex3d-in-human-tumors","",{"@graph":57,"@context":109},[58,72,92],{"@type":59,"itemListElement":60},"BreadcrumbList",[61,65,68,70],{"item":62,"name":63,"@type":64,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":66,"name":67,"@type":64,"position":38},"https://docshare.wps.com/document/","Document",{"item":69,"name":12,"@type":64,"position":43},"https://docshare.wps.com/document/research-report/",{"item":71,"name":13,"@type":64,"position":31},"https://docshare.wps.com/document/a-pan-cancer-analysis-of-mex3d-in-human-tumors/352189/",{"url":71,"name":13,"@type":73,"image":74,"author":79,"headline":13,"publisher":81,"fileFormat":84,"inLanguage":24,"description":14,"dateModified":85,"datePublished":86,"encodingFormat":84,"isAccessibleForFree":87,"interactionStatistic":88},"DigitalDocument",{"url":75,"@type":76,"width":77,"height":78},"https://docshare.wps.com/thumbnails/a-pan-cancer-analysis-of-mex3d-in-human-tumors/352189.png","ImageObject",300,407,{"name":9,"@type":80},"Person",{"url":62,"name":82,"@type":83},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":89,"interactionType":90,"userInteractionCount":20},"InteractionCounter",{"@type":91},"ViewAction",{"@type":93,"mainEntity":94},"FAQPage",[95,101,105],{"name":96,"@type":97,"acceptedAnswer":98},"What is the purpose of this pan-cancer analysis of MEX3D?","Question",{"text":99,"@type":100},"To clarify the relationship between MEX3D expression and tumor biology across diverse human cancer types, addressing the gap left by limited cross-cancer understanding.","Answer",{"name":102,"@type":97,"acceptedAnswer":103},"Which datasets and molecular levels were used to evaluate MEX3D?",{"text":104,"@type":100},"Transcriptomic and proteomic data from TCGA, GTEx, and CPTAC were analyzed, assessing both mRNA and protein expression patterns.",{"name":106,"@type":97,"acceptedAnswer":107},"What clinical relevance is reported for MEX3D expression?",{"text":108,"@type":100},"MEX3D dysregulation correlates with tumor stage in several cancers and is associated with poor overall survival and disease-specific survival across multiple malignancies.","https://schema.org",{"og:url":71,"og:type":111,"og:title":13,"og:site_name":82,"og:description":14},"article",{"robots":113,"canonical":71},"index,follow",{"doc_id":7,"site_id":25},1790194481,{"code":4,"msg":5,"data":117},[118,122,126,130,135,140,144,147,152,155,159],{"id":21,"doc_module":4,"doc_module_name":67,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":38,"doc_module":4,"doc_module_name":67,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":31,"doc_module":4,"doc_module_name":67,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":67,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":67,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":20,"doc_module":4,"doc_module_name":67,"category_name":141,"show_sort_weight":142,"slug":143},"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":67,"category_name":12,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":67,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":67,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":67,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":22,"doc_module":4,"doc_module_name":67,"category_name":160,"show_sort_weight":131,"slug":161},"General","general"]